Anti-Proliferative Effects of Compound A and Its Effect in Combination with Cisplatin in Cholangiocarcinoma Cells

BACKGROUND: Cholangiocarcinoma (CCA) is a fatal cancer with high resistance to anticancer drugs. The development of new drugs or compounds to be used alone or in combination with currently available chemotherapeutic agents to improve the treatment of CCA is needed. Compound A (CpdA), which is a smal...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Asian Pac J Cancer Prev
Main Authors: Junking, Mutita, Rattanaburee, Thidarath, Panya, Aussara, Budunova, Irina, Haegeman, Guy, Yenchitsomanus, Pa-Thai
Formato: Artigo
Idioma:Inglês
Publicado em: West Asia Organization for Cancer Prevention 2020
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7779449/
https://ncbi.nlm.nih.gov/pubmed/32986368
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.31557/APJCP.2020.21.9.2673
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados